Hazard Ratio

Type: Keyphrase
Name: Hazard Ratio
First reported Sep 20 2014 - Updated Sep 20 2014 - 1 reports

PREVAIL Trial Investigator Discusses Pre-Chemo Enzalutamide Indication

Andrew J. RothTomasz M. Beer, MDThe treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) has undergone dramatic changes in recent years, with the most recent advance marked by the pre-chemotherapy approval of enzalutamide ... [Published OncLive - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Rates of stroke following acute MI drop as treatments improve

Risk of ischemic stroke within one year of acute MI dropped by 20 percent over a 10-year span in the general Swedish population in a study published online Sept. 18 in Stroke.Incidence rates of stroke within one year of acute MI observed by the research ... [Published Cardiovascular Business - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

CABG raises quality of life in patients with ischemic left ventricular dysfunction

When treated for ischemic left ventricular dysfunction, patients who underwent CABG reported better quality-of-life compared with guideline therapy patients at different time points throughout follow-up of nearly five years. The CABG group also had lower ... [Published Cardiovascular Business - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Lilly's Combo Treatment Improves OS in Gastric Cancer Patients

Eli Lilly and Co. announced that results of the global Phase 3 trial of ramucirumab (Cyramza) in combination with paclitaxel in patients with advanced gastric (stomach) cancer or gastroesophageal junction (GEJ) adenocarcinoma were published in the online ... [Published Drug Discovery and Development - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Beta-Interferon, Glatiramer Acetate Cost-Effective in MS

BOSTON — The first prospective study to look at long-term therapy with β-interferon and glatiramer acetate ( Copaxone , Teva Neuroscience) in multiple sclerosis (MS) has concluded that these drugs are cost-effective over 6 years of use.Results suggested ... [Published General Medicine eJournal - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

'Real-World' Study Shows 2 Drugs Better Than 1 for COPD

For older adults with chronic obstructive pulmonary disease (COPD), combination therapy with long-acting β-agonists (LABAs) and inhaled corticosteroids (ICSs) produces better outcomes than treatment with LABAs alone, a new study suggests.In a retrospective, ... [Published American Journal of Public Health - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 3 reports

Intravascular ultrasound-guided intervention in patients with chronic total occlusion

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous coronary intervention (PCI). The ... [Published Science Daily - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation

To read this article in full you may need to log in, make a payment or gain access through a site license (see right).Kidney International , (17 September 2014) | doi :10.1038/ki.2014.304 Agnes Debout , Yohann Foucher , Katy Trébern-Launay , Christophe ... [Published Kidney International - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Merck announces data from pivotal Phase 3 fracture outcomes study for odanacatib, an investigational oral, once-weekly treatment for osteoporosis

Merck, known as MSD outside the United States and Canada, has announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis . Odanacatib is Merck's investigational once-weekly cathepsin K inhibitor. ... [Published Medical News Today - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

AGE Levels Associate with Bone Fracture Risk in Aging

Our bones become dangerously weak with advancing age. A lot of this stems from a growing failure of maintenance processes and an imbalance in the bone remodeling that constantly takes place - too much bone removal, and not enough creation. In addition, ... [Published Fight Aging! - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 16 2014 - 1 reports

New Safety And Efficacy Data On Merck's Osteoporosis Drug, Odanacatib

Merck has announced the presentation of new results from their large, ongoing, Phase III trial to examine the safety and efficacy of its osteoporosis drug candidate, odanacatib. a once-weekly, first-in-class, cathepsin K inhibitor. Cathepsin K is an important ... [Published Forbes.com - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Lung Cancer Treatment Disparities in China: A Question in Need of an Answer

Background. Substantial progress has been made in the treatment of malignancies in the in recent years. The goal of this study was to identify the extent to which national treatment guidelines are being used to customize patient care in lung cancer and ... [Published The Oncologist - Sep 15 2014]

Quotes

author Richard Furman, MD, from the Weill Cornell Medical College in New York City, concluded that the addition of idelalisib to rituximab "provided effective durable disease control and improved"
"I know in Finland there is a lot of media coverage of probiotic use. In Germany, probiotics are usually added into infant formula" remarked Dr. Uusitalo
...cancer is a major global health issue," said Richard Gaynor, senior vice president, product development and medical affairs for Lilly Oncology. "We are encouraged by the RAINBOW study results and are pleased that we now have a second Phase 3 trial of ramucirumab which has demonstrated improved survival in advanced gastric cancer patients."
"We did not detect a significant difference in the magnitude of PCI versus CABG treatment effect for patients treated with insulin and those not treated with insulin" conclude the authors

More Content

All (381) | News (347) | Reports (0) | Blogs (33) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
PREVAIL Trial Investigator Discusses Pre-Chemo ... [Published OncLive - Sep 20 2014]
Follow-up of Blood-Pressure Lowering and Glucos... [Published New England Journal of Medicine - Sep 20 2014]
Risk factors for brain metastases in completely... [Published 7thSpace - Sep 20 2014]
Rates of stroke following acute MI drop as trea... [Published Cardiovascular Business - Sep 19 2014]
Boomer Bytes #36: The Lure of Leisure [Published High Country Press - Sep 19 2014]
The Impact of Delayed Chemotherapy on Its Compl... [Published Plosone.org - Sep 19 2014]
Idelalisib (Zydelig) Approved in Europe [Published American Journal of Public Health - Sep 19 2014]
Gilead Cancer Drug Approved in Europe [Published Drug Discovery and Development - Sep 19 2014]
Probiotics Cut Autoimmunity 33% in Infants at R... [Published General Medicine eJournal - Sep 19 2014]
European Commission Grants Marketing Authorizat... [Published Tamar Securities - Sep 19 2014]
CABG raises quality of life in patients with is... [Published Cardiovascular Business - Sep 19 2014]
Novartis data in The Lancet Oncology show LBH58... [Published Value Investing News - Sep 18 2014]
Lilly's Combo Treatment Improves OS in Gastric ... [Published Drug Discovery and Development - Sep 18 2014]
Ramucirumab/Paclitaxel Improves Survival in Sec... [Published PT Community - Sep 18 2014]
Insulin Rx tied to increased major adverse CV e... [Published Medical Xpress - Sep 18 2014]
Beta-Interferon, Glatiramer Acetate Cost-Effect... [Published General Medicine eJournal - Sep 18 2014]
PET-CT Better Than CT in Follicular Lymphoma [Published General Medicine eJournal - Sep 18 2014]
Orexigen Therapeutics (OREX) Presents at Bank o... [Published Seeking Alpha - Sep 18 2014]
CYRAMZA™ In Combination With Paclitaxel Signif... [Published TickerTech.com - Sep 18 2014]
Study: Little difference in shingles risk among... [Published Dermatology Times - Sep 18 2014]
Ramucirumab effective second-line option for NSCLC [Published News-Medical.Net - Sep 17 2014]
Review of thromboembolism treatments finds one ... [Published Cardiovascular Business - Sep 17 2014]
Morbid Obesity: A Significant Risk Factor for F... [Published Journal of Bone and Joint Surgery - Sep 17 2014]
Rheumatoid Arthritis and the Risk of Bipolar Di... [Published Plosone.org - Sep 17 2014]
'Real-World' Study Shows 2 Drugs Better Than 1 ... [Published American Journal of Public Health - Sep 17 2014]
Each additional hour of cold ischemia time sign... [Published Kidney International - Sep 17 2014]
Nephrocalcinosis is a risk factor for kidney fa... [Published Kidney International - Sep 17 2014]
Chronic kidney disease and intensive glycemic c... [Published Kidney International - Sep 17 2014]
AGE Levels Associate with Bone Fracture Risk in... [Published Fight Aging! - Sep 17 2014]
Merck announces data from pivotal Phase 3 fract... [Published Medical News Today - Sep 17 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AGE Levels Associate with Bone Fracture Risk in... [Published Fight Aging! - Sep 17 2014]
Our bones become dangerously weak with advancing age. A lot of this stems from a growing failure of maintenance processes and an imbalance in the bone remodeling that constantly takes place - too much bone removal, and not enough creation. In addition, ...
Increased risk of bipolar disorder and depressi... [Published Multiple Sclerosis Research - Sep 15 2014]
This is an interesting study conducted using the Swedish National Patient Register looking at the risk of developing MS in patients with psychiatric disorders. The paper showed that patients with depression and bipolar disorder are more likely to develop ...
Study: Use of methylphenidate-based ADHD medica... [Published SharpBrains - Aug 20 2014]
ADHD medication enhances the risk of heart problems in children (Science Nordic): “The risk of developing heart problems is twice as big for children taking medicine for Attention Deficit-Hyperactivity Disorder (ADHD) when compared to children not ...
Evidence and colorectal screening policy: a mis... [Published The Incidental Economist (Posts) - Aug 14 2014]
From JAMA, “ Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality “: Importance: Colorectal cancer is a major health burden. Screening is recommended in many countries. Objective: To estimate the effectiveness of ...
Psychiatric problems are more common in MSers [Published Multiple Sclerosis Research - Aug 10 2014]
Brenner P et a. Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study. PLoS One. 2014 Aug 5;9(8):e104165. doi: 10.1371/journal.pone.0104165. eCollection 2014. Background:Psychiatric ...
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.